World's Best Scientists 2026 revealed!
Charles L. Loprinzi

Charles L. Loprinzi

D-Index & Metrics

Medicine

D-Index
123
Citations
59631
World Ranking
3334
National Ranking
1833

Charles L. Loprinzi publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Charles L. Loprinzi sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 762 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Charles L. Loprinzi D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Charles L. Loprinzi sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 123 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Charles L. Loprinzi is affiliated with the Mayo Clinic in the United States and has contributed extensively to the field of Medicine, with a particular focus on Oncology. Their body of work includes 251 publications predominantly within Medicine, of which 74 specifically relate to Oncology. Other significant subfields of study involve Dermatology, Surgery, Genetics, and Pulmonary and Respiratory Medicine.

The scientist has concentrated research efforts on topics such as Cancer Treatment and Pharmacology, Chemotherapy-related skin toxicity, Cancer survivorship and care, Nausea and vomiting management, Cancer-related cognitive impairment studies, Multiple Myeloma Research and Treatments, and Complementary and Alternative Medicine Studies.

Among their recent papers are:

  • Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update (2020, Journal of Clinical Oncology)
  • Management of Cancer Cachexia: ASCO Guideline (2020, Journal of Clinical Oncology)
  • Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology-ASCO Guideline (2022, Journal of Clinical Oncology)
  • ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe (2022, Annals of Oncology)
  • Cancer-related cognitive impairment in patients with non-central nervous system malignancies: an overview for oncology providers from the MASCC Neurological Complications Study Group (2020, Supportive Care in Cancer)

Frequent co-authors in their research include Kathryn J. Ruddy, Fergus J. Couch, Elizabeth Cathcart-Rake, Maryam B. Lustberg, and Jennifer Le-Rademacher. This range of collaborators reflects the multidisciplinary and collaborative nature of their work.

The primary venues for publication reflect this collaborative research approach and include:

  • Journal of Clinical Oncology (25 publications)
  • Supportive Care in Cancer (19 publications)
  • Cancer Research (7 publications)
  • JAMA Oncology (4 publications)
  • Cancers (4 publications)

Best Publications

  • Definition and classification of cancer cachexia: an international consensus

    Kenneth Ch. Fearon;Florian Strasser;Stefan D. Anker;Ingvar Bosaeus

  • A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

    Robert S. Sandler;Susan Halabi;John A. Baron;Susan Budinger

  • Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

    Dawn L. Hershman;Christina Lacchetti;Robert H. Dworkin;Ellen M. Lavoie Smith

  • Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much?

    Sharlene Gill;Charles L. Loprinzi;Daniel J. Sargent;Stephan D. Thomé

  • Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial

    Charles L Loprinzi;John W Kugler;Jeff A Sloan;James A Mailliard

  • Chemotherapy-induced peripheral neuropathy: Prevention and treatment strategies

    Sherry Wolf;Debra Barton;Lisa Kottschade;Axel F Grothey

  • Colorectal Cancer Surveillance: 2005 Update of an American Society of Clinical Oncology Practice Guideline

    Christopher E. Desch;Al B. Benson;Mark R. Somerfield;Patrick J. Flynn

  • Patient-Clinician Communication: American Society of Clinical Oncology Consensus Guideline

    Timothy Gilligan;Nessa Coyle;Richard M. Frankel;Donna L. Berry

  • Megestrol acetate for the prevention of hot flashes

    Charles Lawrence Loprinzi;John C. Michalak;Susan K. Quella;Judith R. O'fallon

  • Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update

    Charles L. Loprinzi;Christina Lacchetti;Jonathan Bleeker;Guido Cavaletti

  • Methodologic lessons learned from hot flash studies.

    Jeff A. Sloan;Charles L. Loprinzi;Paul J. Novotny;Debra L. Barton

  • Phase III Evaluation of Fluoxetine for Treatment of Hot Flashes

    Charles L. Loprinzi;Jeff A. Sloan;Edith A. Perez;Susan K. Quella

  • Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline Summary.

    Dawn L. Hershman;Christina Lacchetti;Charles L. Loprinzi

  • Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study

    Aminah Jatoi;Harold E. Windschitl;Charles L. Loprinzi;Jeff A. Sloan

  • Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.

    Debra L. Barton;Charles L. Loprinzi;Susan K. Quella;Jeff A. Sloan

  • Evaluation of Soy Phytoestrogens for the Treatment of Hot Flashes in Breast Cancer Survivors: A North Central Cancer Treatment Group Trial

    Susan K. Quella;Charles L. Loprinzi;Debra L. Barton;James A. Knost

  • Soy for Breast Cancer Survivors: A Critical Review of the Literature

    Mark J. Messina;Charles L. Loprinzi

  • Apixaban and dalteparin in active malignancy-associated venous thromboembolism: The ADAM VTE trial.

    Robert D. McBane;Waldemar E. Wysokinski;Jennifer G. Le-Rademacher;Tyler Zemla

  • Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group.

    C L Loprinzi;J A Laurie;H S Wieand;J E Krook

  • Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting

    Rudolph M. Navari;Rui Qin;Kathryn J. Ruddy;Heshan Liu

Frequent Co-Authors

Jeff A. Sloan
Jeff A. Sloan Mayo Clinic
Paul J. Novotny
Paul J. Novotny Mayo Clinic
Shaker R. Dakhil
Shaker R. Dakhil University of Kansas
Axel Grothey
Axel Grothey University of Tennessee at Knoxville
Thomas J. Smith
Thomas J. Smith Johns Hopkins University School of Medicine
Daniel J. Schaid
Daniel J. Schaid Mayo Clinic
Edith A. Perez
Edith A. Perez Mayo Clinic
David P. Steensma
David P. Steensma Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine but seeking flexible education options, the healthcare field offers a range of online degree pathways. Many aspiring nurses start by exploring the affordable rn to bsn programs now widely available, which cater to working professionals looking to advance their credentials without significant debt.

Non-nursing graduates can also consider direct entry msn online routes, allowing faster entry into advanced nursing roles with a specialized focus. If entry barriers are a concern, prospective students may want to look at the easiest rn program to get into for a smoother admission process and streamlined transition into nursing careers.

Not all medical careers require direct patient care. Administrative roles are growing quickly, and students can train at medical billing and coding schools online with financial aid to tap into an in-demand healthcare career from home. Each of these paths provides unique entry points to the U.S. healthcare system, catering to diverse backgrounds and future goals.

Best Scientists Citing Charles L. Loprinzi

Trending Scientists

Recently Published Articles